Bionime Corporation (4737) Signed Agreement with GE.
To Which item it meets: Article 2 paragraph 10
(TWSE Procedures for Verification and Disclosure of Material Information of Companies with Listed Securities)
Date of announcement: March 16th, 2011
Descriptions:
| Date of Event | March 16th, 2011 |
| Counterparty to the Contract | GE. |
| Relationship to the corporatio | None |
| Starting and ending dates of the contract | Effective from March 15th, 2011 |
| Major contents | On March 16th, 2011 Taiwan Time (March 15, 2011 US Central Time), GE and Bionime signed the Licensing Agreement. |
| Restrictive covenants | As disclosed in the agreement. |
| Effects on company Finances and Business | It is expected the cooperation will bring positive impacts on company business. |
| Concrete Objective | Strategic global cooperation during term of Licensing Agreement in diabetes technology. |
